Samuel Mialhe

Samuel Mialhe is a notable inventor based in Castres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for therapeutic use. With a total of 3 patents to his name, Mialhe's work focuses on innovative solutions for human health.

Latest Patents

Mialhe's latest patents include groundbreaking inventions such as "Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans." This invention relates to diarylpyridazinone derivatives that block potassium Kv channels, specifically Kv1.5, Kv4.3, and Kv11.1 channels. The compounds have a general formula that allows for various groupings, including halogens and alkyl groups, which are essential for their therapeutic applications. Another significant patent is "Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics." This invention features compounds characterized by a general formula that enhances their effectiveness in treating human ailments.

Career Highlights

Samuel Mialhe is currently associated with Pierre Fabre Medicament, a company known for its commitment to innovation in the pharmaceutical industry. His work at this organization has allowed him to focus on developing new therapeutic compounds that can improve patient outcomes.

Collaborations

Mialhe has collaborated with esteemed colleagues such as Elisabeth Dupont-Passelaigue and Didier Junquero. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Samuel Mialhe's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing human health. His work continues to inspire future developments in therapeutic compounds.